IOSP — Innospec Income Statement
0.000.00%
- $2.26bn
- $1.97bn
- $1.85bn
- 86
- 55
- 76
- 85
Annual income statement for Innospec, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,193 | 1,483 | 1,964 | 1,949 | 1,845 |
Cost of Revenue | |||||
Gross Profit | 343 | 435 | 587 | 591 | 543 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,159 | 1,351 | 1,776 | 1,787 | 1,823 |
Operating Profit | 33.7 | 132 | 187 | 162 | 22.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 39.7 | 134 | 185 | 174 | 41.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.7 | 93.1 | 133 | 139 | 35.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 28.7 | 93.1 | 133 | 139 | 35.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.7 | 93.1 | 133 | 139 | 35.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.49 | 3.81 | 5.42 | 6.01 | 6.17 |
Dividends per Share |